TG Therapeutics, Inc. (TGTX)
NASDAQ: TGTX · Real-Time Price · USD
36.72
-1.23 (-3.24%)
At close: Jun 27, 2025, 4:00 PM
37.00
+0.28 (0.76%)
Pre-market: Jun 30, 2025, 8:00 AM EDT
TG Therapeutics Employees
TG Therapeutics had 338 employees as of December 31, 2024. The number of employees increased by 74 or 28.03% compared to the previous year.
Employees
338
Change (1Y)
74
Growth (1Y)
28.03%
Revenue / Employee
$1,143,154
Profits / Employee
$115,828
Market Cap
5.36B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| AbbVie | 55,000 |
TGTX News
- 4 days ago - TG Therapeutics: Another Possible Avenue Of MS Growth With Azer-Cel - Seeking Alpha
- 24 days ago - TG Therapeutics to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference - GlobeNewsWire
- 4 weeks ago - TG Therapeutics: Estimates Could Soon Be Raised Again - Seeking Alpha
- 4 weeks ago - TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® in Multiple Sclerosis at the 2025 Consortium of Multiple Sclerosis Centers Annual Meeting - GlobeNewsWire
- 7 weeks ago - TG Therapeutics Falls Short On Earnings, But Briumvi Sales Steal the Show - Benzinga
- 7 weeks ago - TG Therapeutics: Share Price Slip On Q1 Earnings Unsurprising Given Challenges - Seeking Alpha
- 7 weeks ago - TG Therapeutics, Inc. (TGTX) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - TG Therapeutics Reports First Quarter 2025 Financial Results and Raises BRIUMVI Full Year Revenue Guidance - GlobeNewsWire